$IMCR is giving a GREAT IPO LONG opportunity today

IPO intraday trading strategy idea

Immunocore is a developer of a novel class of TCR (T cell receptor) bispecific immunotherapies called ImmTAX – Immune mobilizing monoclonal TCRs Against X disease – designed to treat a broad range of diseases, including cancer, infectious and autoimmune.

The share price is rising and gonna continue this trend today.

The demand for shares of the company still looks higher than the supply.

These and other conditions can cause a rise in the share price today.

So I opened a long position from $42,41;
stop-loss — $35,71;
take-profit — 61,69/MOC price.

Do not view this idea as a recommendation for trading or investing. It is published only to introduce my own vision.
Always do your own analysis before making deals. When you use any materials, do not rely on blind trust.
You should remember that isolated deals do not give systematic profit, so trade/invest using a developed strategy.

If you like my content, you can subscribe to the news and receive my fresh ideas.
intradayIPOipo-stockipo-trademoenysuccessSupply and DemandSupport and ResistancetraderlifestyleTrend Analysis

More information: fondexx.pro/

!!! Join our trader's chat !!!

Here ==> t.me/fndxworld

We build a cozy community of professional traders
Juga pada:

Penerbitan berkaitan

Penafian